Mikael Segerlantz
Lund University(SE)Healthcare in Sweden(SE)
Publications by Year
Research Areas
Childhood Cancer Survivors' Quality of Life, Palliative Care and End-of-Life Issues, Growth Hormone and Insulin-like Growth Factors, Pain Management and Opioid Use, Pediatric Pain Management Techniques
Most-Cited Works
- → Growth Hormone Replacement Therapy Induces Insulin Resistance by Activating the Glucose-Fatty Acid Cycle(2003)135 cited
- → Inhibition of the Rise in FFA by Acipimox Partially Prevents GH-Induced Insulin Resistance in GH-Deficient Adults(2001)63 cited
- → Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults(2003)36 cited
- → End-of-Life Treatments in Pediatric Patients at a Government Tertiary Cancer Center in India(2018)22 cited
- → Insulin Sensitivity in Adults with Growth Hormone Deficiency and Effect of Growth Hormone Treatment(2005)19 cited
- → Prescription of pain medication among older cancer patients with and without an intellectual disability: a national register study(2019)14 cited
- → End‐of‐life care among older cancer patients with intellectual disability in comparison with the general population: a national register study(2020)12 cited
- → Low-Dose Oral Ketamine for Procedural Analgesia in Pediatric Cancer Patients Undergoing Lumbar Puncture at a Resource-Limited Cancer Hospital in India(2019)9 cited
- → Low-dose oral ketamine as a procedural analgesia in pediatric cancer patients undergoing bone marrow aspirations at a resource-limited cancer hospital in India(2019)7 cited
- → Cancer Treatment and End-of-Life Care(2018)7 cited